Martin Shkreli was a hedge fund manager and former chief executive officer of the pharmaceutical firms Retrophin and Turing Pharmaceuticals He was best known for being a "pharma bro", and for raising the Turing Pharmaceuticals price of the antiparasitic drug Daraprim by over 5000%, from $13.50 to $750 a pill Five years ago, Shkreli was[...]
